Table 1 Clinical characteristics of the ovarian carcinoma patients
From: CHEK2 1100delC mutation in Russian ovarian cancer patients
Groups | Number | (%) |
|---|---|---|
Age (years) | Â | Â |
   ≤ 40 | 34 | 12.7 |
   41–60 | 160 | 59.7 |
   ≥ 61 | 74 | 27.6 |
Mean age: 53.1 years | Â | Â |
Age range: 21–89 years |  |  |
T status | Â | Â |
   T = 1 | 44 | 16.4 |
   T>1 | 211 | 78.7 |
   Non-informative | 13 | 4.9 |
N status | Â | Â |
   N = 0 | 101 | 37.7 |
   N = 1 | 52 | 19.4 |
   Nx | 102 | 38.1 |
   Non-informative | 13 | 4.9 |
M status | Â | Â |
   M = 0 | 174 | 64.9 |
   M = 1 | 55 | 20.5 |
   Mx | 22 | 8.2 |
   Non-informative | 13 | 4.9 |
Tumour differentiation | Â | Â |
   Grade 1 | 35 | 13.1 |
   Grade 2 | 73 | 27.2 |
   Grade 3 | 160 | 59.7 |
Histology | Â | Â |
   Serous adenocarcinoma | 235 | 87.7 |
   Mucinous adenocarcinoma | 8 | 3.0 |
   Adenocarcinoma, unspecified | 14 | 5.2 |
   Other | 10 | 3.7 |
   Non-informative | 1 | 0.4 |
Total | 268 | 100.0 |